Agreed with you @dazaliam , BGS is currently being rerated. There is no stale holders tossing out, queuing to exit, but shareholders holding tightly. Buyers taking what is on offer and sellers are thin and few. The real test could be nearer the end of the month when the share price is ATH and some holders are tempted with immediate profits.
Wishful thinking! I think not, with gold permits, aero mag survey results, more drilling results for more gold and lithium,JORC, PSF version 2, appointment of new and additional executives and announcements of JV partner/ off takers. To bring us up to the level of our peers, we could be looking at $2-3 before the end of the year. Happy holding and riding, shareholders.
BGS Chart !, page-1386
-
- There are more pages in this discussion • 670 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online